Jorge Garces has joined GenMark Diagnostics as senior vice president of R&D, the company said recently.
Garces most recently served as CEO and president of Enigma Diagnostics' US business. Prior to that, he was VP of R&D and site operations manager at Hologic. He has also held positions at Third Wave Technologies, Genzyme Genetics, and Athena Diagnostics.
Garces holds a BS in biology from Brooklyn College and a PhD in cell and molecular biology from the City University of New York. He completed his postdoc at the University of Massachusetts Medical School and received an MBA from the Kellogg Graduate School of Management.
NanoMR said this week that it has appointed Jim Macemon as vice president of product development.
Macemon will oversee the design and manufacture of disposable cassettes for NanoMR's Pathogen Capture System for the blood culture market. Prior to joining NanoMR, Macemon was vice president of operations at Luminous Medical. He has also held senior positions at Baxter Healthcare, Richardson-Vicks, and SpaceLabs Medical.
The Pathogen Capture System uses immunomagnetic technology to recover microbial cells or other specific cell types, such as circulating tumor and fetal cells, directly from drawn blood. The system can deliver purified DNA from captured cells in less than one hour, the company said. Using conventional methods such as PCR, causative agents can be identified in less than two hours, making it possible for physicians to begin appropriate patient therapy in suspected cases of bloodstream infection.
Albuquerque, NM-based NanoMR said that it plans to begin clinical trials for the PCS in Europe within the next year.